Namibia has completed its first bone marrow transplant, marking a significant milestone for the country’s medical sector. However, the treatment is currently accessible to only about 15% of the population, highlighting the need to expand the service into the public healthcare system, according to Clinical Haematologist Dr Kudakwashe Simba.
On 11 November 2025, Namibia achieved the successful completion of its first autologous stem cell transplant, a development that significantly reduces the need for patients to seek life-saving treatment abroad.
An autologous stem cell transplant uses healthy stem cells collected from a patient’s own body and stored before high-dose chemotherapy or radiation, which are administered to kill cancer cells.
The achievement, two years in the making, was realised through the Namibia Bone Marrow Transplant Collaboration Group, consisting of Dr Simba as the transplant physician, the Namibian Oncology Centre, the Blood Transfusion Service of Namibia (NamBTS), Pathcare Namibia, the Cancer Association of Namibia (CAN), and the Windhoek Central Hospital Oncology team. The procedure was performed by Dr Simba at the Namibia Oncology Centre (NOC) in Windhoek.
Dr Simba said the transplant is primarily used for blood and bone marrow cancers such as multiple myeloma and various lymphomas.
“Currently, the service is available in the private sector, serving only about 15% of the population. Next year, we aim to extend the programme into the public sector so vulnerable groups can also benefit,” he told Nampa.
He added that plans are underway to introduce transplants requiring donor stem cells, which will expand the range of conditions that can be treated locally.
“Once the system is fully streamlined, we plan to introduce allogeneic stem cell transplants, which require a donor and will greatly expand the conditions we can treat locally,” he said.
An allogeneic stem cell transplant uses healthy stem cells from a donor to replace diseased or damaged bone marrow.
“By performing transplants locally, we eliminate accommodation, transport, visa and foreign hospital costs. Medical aid funds also benefit, as costs are significantly lower than foreign centres,” CEO of the Cancer Association of Namibia, Rolf Hansen, said in a statement issued last week.
-Nampa

